MKI67 and obesity disorder: Indeed, administration of Liraglutide (Fig. EV1O–P) also very significantly decreased the number of both Ki67+ cells both in the MBH and the ME, suggesting that different anti-obesity compounds exert similar effects on hypothalamic proliferation in the context of HFD.